Helocyte
Helocyte is a clinical-stage biopharmaceutical company developing novel immunotherapies for the prevention and treatment of cancer.
Helocyte is active in the biotechnology, health care, pharmaceutical, therapeutics space based in Greater New York Area, East Coast, Northeastern US, founded in 2015.
Its activity falls under biotechnology, health care, pharmaceutical, therapeutics; the profile below is assembled from public directory data.
The business is associated with Greater New York Area, East Coast, Northeastern US.
The company is listed at the Grant stage of development.
Recorded headcount: c_00001_00010 employees.
Public records show total funding of about $8.2M.
| Sector | Biotechnology, Health Care, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | Greater New York Area, East Coast, Northeastern US |
| Founded | 2015 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $8,220,000 |
Website: www.helocyte.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account